News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
24,981 Results
Type
Article (927)
Press Release (24054)
Section
Business (12748)
Career Advice (54)
Deals (1604)
Drug Delivery (2)
Drug Development (2101)
FDA (363)
Job Trends (606)
News (16015)
Policy (685)
Tag
Academia (42)
Accelerated approval (2)
Allergies (1)
Alliances (701)
ALS (3)
Alzheimer's disease (40)
Antibody-drug conjugate (ADC) (10)
Approvals (396)
Artificial intelligence (6)
Autoimmune disease (3)
Bankruptcy (2)
Best Places to Work (556)
Biosimilars (6)
Biotechnology (1)
Bladder cancer (5)
Brain cancer (1)
Breast cancer (30)
Cancer (147)
Cardiovascular disease (10)
Career advice (40)
Career pathing (1)
CAR-T (5)
CDC (1)
Cell therapy (13)
Cervical cancer (1)
Clinical research (1914)
Collaboration (9)
Compensation (45)
COVID-19 (43)
CRISPR (5)
C-suite (2)
Cystic fibrosis (4)
Data (203)
Depression (2)
Diabetes (12)
Diagnostics (232)
Digital health (1)
Drug discovery (2)
Drug pricing (2)
Duchenne muscular dystrophy (2)
Earnings (12765)
Events (2513)
Executive appointments (2)
FDA (572)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (16)
Gene editing (5)
Gene therapy (11)
GLP-1 (26)
Government (94)
Guidances (140)
Healthcare (661)
HIV (1)
IgA nephropathy (3)
Immunology and inflammation (4)
Indications (8)
Infectious disease (52)
Inflammatory bowel disease (9)
Influenza (1)
Intellectual property (3)
Interviews (5)
IPO (1302)
Job creations (87)
Job search strategy (38)
Labor market (1)
Layoffs (11)
Legal (130)
Liver cancer (5)
Lung cancer (28)
Lymphoma (16)
Manufacturing (4)
MASH (4)
Medical device (670)
Medtech (673)
Mergers & acquisitions (332)
Metabolic disorders (30)
Multiple sclerosis (5)
NASH (1)
Neurodegenerative disease (6)
Neuropsychiatric disorders (4)
Neuroscience (66)
NextGen: Class of 2026 (137)
Non-profit (112)
Obesity (10)
Opinion (4)
Ovarian cancer (3)
Pain (1)
Pancreatic cancer (1)
Parkinson's disease (5)
Patents (2)
Patient recruitment (3)
Peanut (1)
People (527)
Pharmacy benefit managers (2)
Phase 1 (428)
Phase 2 (745)
Phase 3 (842)
Pipeline (524)
Postmarket research (105)
Preclinical (159)
Prostate cancer (7)
Psychedelics (1)
Radiopharmaceuticals (5)
Rare diseases (15)
Real estate (79)
Regulatory (564)
Reports (4)
Research institute (36)
Resumes & cover letters (14)
RSV (6)
Schizophrenia (9)
Series A (1)
Series B (4)
Sickle cell disease (2)
Spinal muscular atrophy (3)
Startups (48)
Vaccines (10)
Weight loss (7)
Women's health (3)
Date
Last 7 days (25)
Last 30 days (87)
Last 365 days (1407)
2026 (110)
2025 (1443)
2024 (1655)
2023 (1814)
2022 (2059)
2021 (2078)
2020 (1823)
2019 (1372)
2018 (1070)
2017 (792)
2016 (440)
2015 (676)
2014 (578)
2013 (286)
2012 (351)
2011 (5655)
2010 (463)
Location
Africa (21)
Alabama (1)
Arizona (5)
Asia (1478)
Australia (146)
California (539)
Canada (121)
China (25)
Colorado (28)
Connecticut (27)
Delaware (23)
Europe (3136)
Florida (68)
Georgia (13)
Illinois (53)
India (5)
Indiana (42)
Japan (14)
Kansas (3)
Kentucky (1)
Louisiana (6)
Maine (6)
Maryland (56)
Massachusetts (326)
Michigan (16)
Minnesota (44)
Missouri (7)
Montana (3)
Nevada (5)
New Hampshire (8)
New Jersey (186)
New York (135)
North Carolina (65)
Northern California (287)
Ohio (6)
Pennsylvania (112)
South America (33)
Southern California (215)
Tennessee (4)
Texas (51)
United States (1904)
Utah (27)
Virginia (13)
Washington D.C. (1)
Washington State (52)
Wisconsin (7)
24,981 Results for "132".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hydreight Reports 132% YoY Revenue Increase in Q3 2025 and Fourth Consecutive Quarter of Profitability, Highlighting Strong Multi-Vertical Performance
November 27, 2025
·
16 min read
Press Releases
ARTBIO Announces $132 Million Series B Financing to Advance Pipeline of Alpha Radioligand Therapies and Expand Manufacturing and Supply Chain Infrastructure
July 30, 2025
·
3 min read
Press Releases
Azafaros to Present at BIO International Convention 2025 Following Successful €132M Series B Financing
June 9, 2025
·
4 min read
Biotech Beach
Endeavor BioMedicines Raises $132.5 Million Oversubscribed Series C Financing to Advance Pipeline of Transformational Medicines
Endeavor BioMedicines, Inc. today announced the closing of a $132.5 million Series C financing, including the conversion of a $5 million convertible instrument.
April 24, 2024
·
4 min read
Biotech Beach
Alterome Therapeutics Raises $132 Million in Series B Financing Led by Goldman Sachs Alternatives
Alterome Therapeutics, Inc., a biopharmaceutical company pioneering the development of next generation, small molecule targeted therapies for the treatment of cancer, announced the closing of a $132 million Series B financing.
April 3, 2024
·
4 min read
Press Releases
Azafaros Secures € 132M in Oversubscribed Series B Financing to Advance Phase 3 Clinical Programs of Innovative Therapies in Lysosomal Storage Disorders
May 13, 2025
·
6 min read
Press Releases
Click Therapeutics Announces FDA Marketing Authorization for CT-132, the First Prescription Digital Therapeutic for the Preventive Treatment of Episodic Migraine in the United States
April 15, 2025
·
10 min read
Press Releases
Oral Biologics Market Size to Hit USD 132.6 Billion by 2030, Coherent Market Insights
January 9, 2025
·
1 min read
Press Releases
In Vitro Diagnostics Market Size to Attain USD 132.18 Bn by 2034
December 17, 2024
·
14 min read
Prostate cancer
AstraZeneca’s Truqap Posts Another Pivotal Disappointment as Phase III Prostate Cancer Study Fails
The drug, a small molecule protein inhibitor, brought in $132 million in the first quarter, missing consensus estimates by 17%.
April 30, 2025
·
2 min read
·
Tristan Manalac
1 of 2,499
Next
